24424-99-5 + 5874-57-7 = 95715-85-8 反应条件:1.1 Reagents: Triethylamine Solvents: Tetrahydrofuran; Rt -> 0 °C1.2 Solvents: Tetrahydrofuran; < 1 H,0 °C; 14 H,Rt; 3 H,50 °C 标题:Synthesis Of D-Abrines By Palladium-Catalyzed Reaction Of Ortho-Iodoanilines With N-Boc-N-Methylalanyl-Substituted Acetaldehyde And Acetylene 作者:Danner,Paulami; Morkunas,Marius; Maier,Martin E. 参考文献:Organic Letters 日期:2013 卷标:15(10) 页码:2474-2477]
24424-99-5 + 5874-57-7 = 95715-85-8 反应条件:1.1 Reagents: Diisopropylethylamine Solvents: Dichloromethane; Rt; Overnight,Rt 标题:Piperidine Derivatives As Aspartic Protease Inhibitors And Their Preparation,Pharmaceutical Compositions And Use In The Treatment Of Aspartic Protease Mediated Diseases 参考文献:World Intellectual Property Organization]
24424-99-5 + 5874-57-7 = 95715-85-8 反应条件:1.1 Reagents: Sodium Bicarbonate Solvents: Tetrahydrofuran,Water; 12 H,Rt 标题:Novel Peptidomimetic Cysteine Protease Inhibitors As Potential Antimalarial Agents 作者:Micale,Nicola; Kozikowski,Alan P.; Ettari,Roberta; Grasso,Silvana; Zappala,Maria; Et Al 参考文献:Journal Of Medicinal Chemistry 日期:2006 卷标:49(11) 页码:3064-3067
Boc-D-丝氨酸,重氮甲烷 反应生成 Boc-D-丝氨酸甲酯 参考文献:Nimkar,Sanjay;Menaldino,David;Merrill,Alfred H.;Liotta,Dennis,Tetrahedron Lett.,29,(1988) N 25,C. 3037-3040 标题:Nimkar,Sanjay;Menaldino,David;Merrill,Alfred H.;Liotta,Dennis,Tetrahedron Lett.,29,(1988) N 25,C. 3037-3040
专利号:US-2004110228-A1 优先权日:2002-04-01 标 题:Combinatorial organic synthesis of unique biologically active compounds 发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M 摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.
专利号:US-8487108-B2 优先权日:2005-11-14 标题 :Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors 发明人:BALDWIN JOHN J; CLAREMON DAVID A; TICE COLIN; CACATIAN SALVACION; DILLARD LAWRENCE W; ISHCHENKO ALEXEY V; YUAN JING; XU ZHENRONG; MCGEEHAN GERARD; SIMPSON ROBERT D; SINGH SURESH B; ZHAO WEI; FLAHERTY PATRICK T 权利人:BALDWIN JOHN J; CLAREMON DAVID A; TICE COLIN; CACATIAN SALVACION; DILLARD LAWRENCE W; ISHCHENKO ALEXEY V; YUAN JING; XU ZHENRONG; MCGEEHAN GERARD; SIMPSON ROBERT D; SINGH SURESH B; ZHAO WEI; FLAHERTY PATRICK T; VITAE PHARMACEUTICALS INC 摘要:The present invention is directed to aspartic protease inhibitors. Certain aspartic protease inhibitors of the invention can be represented by the following structural formula or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.
专利号:US-6995142-B2 优先权日:1998-04-30 标题 :Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis 发明人:DRAGOVICH PETER SCOTT; WEBBER STEPHEN EVAN; PRINS THOMAS JAY; ZHOU RU; MARAKOVITS JOSEPH TIMOTHY; JOHNSON JR THEODORE O 权利人:AGOURON PHARMA 摘要:Peptido and peptidomimetic compounds of the formula: n nwherein the formula variables are as defined in the disclosure, advantageously inhibit or block the biological activity of the picornaviral 3C protease. These compounds, as well as pharmaceutical compositions containing these compounds, are useful for treating patients or hosts infected with one or more picornaviruses, such as RVP. Intermediates and synthetic methods for preparing such compounds are also provided.